Graybug Vision Inc. (GRAY) Appoints Dirk Sauer to its Board

Go back to Graybug Vision Inc. (GRAY) Appoints Dirk Sauer to its Board

Graybug Vision Appoints Dirk Sauer to Board of Directors

April 13, 2022 4:05 PM UTC

BALTIMORE, April 13, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced the appointment of Dirk Sauer, PhD, to the Graybug Board of Directors, effective April 13, 2022. Dr. Sauer will serve as a member of the Nomination and Corporate Governance Committee of the Board. He will also chair the Science and Innovation Committee, the purpose of which is to advise the Board on the companys research and development as well as clinical manufacturing and control strategies.

... More